These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15829128)

  • 41. Testosterone-induced hyperprolactinaemia in a patient with a disturbance of hypothalamo-pituitary regulation.
    Nicoletti I; Filipponi P; Fedeli L; Ambrosi F; Gregorini G; Santeusanio F
    Acta Endocrinol (Copenh); 1984 Feb; 105(2):167-72. PubMed ID: 6695548
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism.
    Merza Z; Blumsohn A; Mah PM; Meads DM; McKenna SP; Wylie K; Eastell R; Wu F; Ross RJ
    Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anejaculation as the presenting feature of pituitary microadenoma.
    Nair S; Milsom S
    Fertil Steril; 2008 Nov; 90(5):2012.e21-3. PubMed ID: 18394608
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy.
    Rhoden EL; Morgentaler A
    Int J Impot Res; 2006; 18(2):201-5. PubMed ID: 16177827
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Osteoporosis in men with hyperprolactinemic hypogonadism.
    Greenspan SL; Neer RM; Ridgway EC; Klibanski A
    Ann Intern Med; 1986 Jun; 104(6):777-82. PubMed ID: 3706929
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does testosterone have a role in erectile function?
    Mikhail N
    Am J Med; 2006 May; 119(5):373-82. PubMed ID: 16651047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Case report: treatment of androgen deficiency in the aging male.
    Hernandez A; Baum N
    Postgrad Med; 2008 Nov; 120(4):73-7. PubMed ID: 19020368
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia.
    Yuan HN; Wang CY; Sze CW; Tong Y; Tan QR; Feng XJ; Liu RM; Zhang JZ; Zhang YB; Zhang ZJ
    J Clin Psychopharmacol; 2008 Jun; 28(3):264-370. PubMed ID: 18480682
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Testosterone replacement therapy for treatment refractory cluster headache.
    Stillman MJ
    Headache; 2006 Jun; 46(6):925-33. PubMed ID: 16732838
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The diagnosis and therapy of subclinical pituitary adenoma apoplexy].
    Li JL; Yu CJ
    Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(13):879-81. PubMed ID: 16083609
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The psychosocial impact of Klinefelter syndrome--a 10 year review.
    Simm PJ; Zacharin MR
    J Pediatr Endocrinol Metab; 2006 Apr; 19(4):499-505. PubMed ID: 16759035
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Postoperative pituitary hormonal disturbances and hormone replacement therapy time and dosage in children with craniopharyngiomas.
    Li GM; Sun XJ; Shao P
    Chin Med J (Engl); 2008 Oct; 121(20):2077-82. PubMed ID: 19080279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy.
    Sarosdy MF
    Cancer; 2007 Feb; 109(3):536-41. PubMed ID: 17183557
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Testosterone replacement in elderly men.
    Baum NH; Crespi CA
    Geriatrics; 2007 Sep; 62(9):15-8. PubMed ID: 17824721
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Skeletal effects of long-term estrogen and testosterone replacement treatment in a man with congenital aromatase deficiency: evidences of a priming effect of estrogen for sex steroids action on bone.
    Rochira V; Zirilli L; Madeo B; Aranda C; Caffagni G; Fabre B; Montangero VE; Roldan EJ; Maffei L; Carani C
    Bone; 2007 Jun; 40(6):1662-8. PubMed ID: 17400043
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Feedback inhibition of gonadotropins by testosterone in men with hypogonadotropic hypogonadism: comparison to the intact pituitary-testicular axis in primary hypogonadism.
    Shimon I; Lubina A; Gorfine M; Ilany J
    J Androl; 2006; 27(3):358-64. PubMed ID: 16474013
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of endoscopic endonasal approach to pituitary tumours: HUKM experience.
    Gendeh BS; Doi M; Selladurai BM; Khalid BA; Jegan T; Misiran K
    Med J Malaysia; 2006 Aug; 61(3):343-8. PubMed ID: 17240587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Testosterone replacement therapy for late-onset hypogonadism.
    Cunningham GR
    Nat Clin Pract Urol; 2006 May; 3(5):260-7. PubMed ID: 16691239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of selected patients with hyperprolactinaemia by partial hypophysectomy.
    Scanlon MF; Peters JR; Thomas JP; Richards SH; Morton WH; Howell S; Williams ED; Hourihan M; Hall R
    Br Med J (Clin Res Ed); 1985 Nov; 291(6508):1547-50. PubMed ID: 3933746
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of hyperprolactinemia and its control on metabolic diseases.
    Auriemma RS; De Alcubierre D; Pirchio R; Pivonello R; Colao A
    Expert Rev Endocrinol Metab; 2018 Mar; 13(2):99-106. PubMed ID: 30058862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.